Streetwise Reports
The Gold Report
The Energy Report
The Life Sciences Report
Research Reports
Streetwise Reports
The Gold Report
The Energy Report
The Life Sciences Report
Research Reports
The Life Sciences Report
Menu
Articles
Biotechnology / Pharmaceuticals
Cannabis
Healthcare Services
Life Sciences Tools & Diagnostics
Medical Devices
Nutraceuticals
Psychedelics
Disclosures
Featured news in
The Life Sciences Report
Cesca Therapeutics Inc.
(KOOL:NASDAQ)
Cesca Therapeutics Set to Join Russell Microcap® Index (6/23/2017)
view
Sunesis Pharmaceuticals Inc.
(SNSS:NASDAQ)
Sunesis Pharmaceuticals Announces Presentation of Updated Results from Washington University-Sponsored Phase 1/Cohort Expansion Trial of Vosaroxin Plus Azacitidine in Patients with MDS at the EHA Annual Meeting (6/23/2017)
view
DURECT Corp.
(DRRX:NASDAQ)
DURECT Completes Enrollment in PERSIST, Phase 3 trial for POSIMIR® (6/22/2017)
view
Mesoblast Ltd.
(MESO:NASDAQ; MSB:ASX)
Mesoblast Rheumatoid Arthritis Trial Results Presented at EULAR Annual European Congress of Rheumatology (6/22/2017)
view
Resverlogix Corp.
(RVX:TSX)
Resverlogix Comments on TSX Trader Notes (6/21/2017)
view
DURECT Corp.
(DRRX:NASDAQ)
Featured Company News - DURECT-SANDOZ Collaboration Clears HSR Review; Paves Path for POSIMIR Development and Marketing in the U.S. (6/21/2017)
view
RXi Pharmaceuticals Corp.
(PHIO:NASDAQ)
RXi Pharmaceuticals Announces Completion of Enrollment of Phase 1/2 Clinical Trial with RXI-109 for Retinal Scarring (6/21/2017)
view
Celgene Corp.
(CELG:NASDAQ)
Biotech Stock Roundup: Clovis Soars on Rubraca Data, Seattle Hit by Study Halt (6/21/2017)
view